Becton Dickinson (BDX) Common Equity (2009 - 2026)
Becton Dickinson's (BDX) quarterly Common Equity came in at $24.1 billion in Q1 2026, up 33418.06% year-on-year from N/an in Q1 2025, and up 6404.85% on a QoQ basis from $371.0 million in Q4 2025.
Becton Dickinson (BDX) Common Equity (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Common Equity data on file, last reported at $24.1 billion in Q1 2026.
- On a quarterly basis, Common Equity rose 33418.06% year-over-year to $24.1 billion in Q1 2026; TTM through Mar 2026 was $24.1 billion, a 33418.06% increase from a year earlier, with the FY2025 full-year figure at $25.4 billion, up 4658.35% from the prior year.
- Common Equity for Q1 2026 stood at $24.1 billion, up from $371.0 million in the prior quarter.
- Over the last five years, Common Equity for BDX reached as high as $25.5 billion in Q2 2025 and fell as low as -$8.3 billion in Q2 2023.
- Historically, Common Equity has averaged $8.6 billion across 5 years, with a median of $371.0 million in 2023.
- Across the five-year window, Common Equity tumbled 142.65% in 2023 and jumped 37200.0% in 2025, its largest moves.
- Year by year, Common Equity stood at $365.0 million in 2022, then climbed by 1.64% to $371.0 million in 2023, then plunged by 100.27% to -$1.0 million in 2024, then soared by 37200.0% to $371.0 million in 2025, then surged by 6404.85% to $24.1 billion in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $24.1 billion in Q1 2026, $371.0 million in Q4 2025, and $25.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 22.13 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 24.13 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 11.27 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 6.49 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 8.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.97 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.15 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 6.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.13 Bn |
| Dec 31, 2025 | 371.00 Mn |
| Sep 30, 2025 | 25.39 Bn |
| Jun 30, 2025 | 25.47 Bn |
| Mar 31, 2025 | 72.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -557.00 Mn |
| Jun 30, 2024 | 371.00 Mn |
| Mar 31, 2024 | 15.80 Bn |
| Dec 31, 2023 | 371.00 Mn |
| Jun 30, 2023 | -8.32 Bn |
| Mar 31, 2023 | 15.56 Bn |
| Dec 31, 2022 | 365.00 Mn |
| Sep 30, 2022 | 23.00 Mn |
| Jun 30, 2022 | 19.51 Bn |
| Mar 31, 2022 | 19.50 Bn |
| Dec 31, 2021 | -7.86 Bn |
| Sep 30, 2021 | 13.83 Bn |
| Jun 30, 2021 | 19.28 Bn |
| Mar 31, 2021 | 13.56 Bn |